Results 231 to 240 of about 48,847 (353)

Human hypoxia models in aerospace medicine: Potential applications for human pharmacological research

British Journal of Clinical Pharmacology, Volume 92, Issue 1, Page 58-72, January 2026.
Aerospace medicine required controlled terrestrial models to investigate influences of altered atmosphere conditions, such as hypoxia, on human health and performance. These models could potentially be expanded to encompass disease conditions or treatment targets regulated through hypoxia or hypercapnia.
Titiaan E. Post, Cayla Denney, Adam Cohen, Jens Jordan, Ulrich Limper   +4 more
wiley   +1 more source

Ventricular Fibrillation From Spontaneous Coronary Artery Dissection in a Patient With Atrioventricular Nodal Re-entrant Tachycardia: Rationale for Implantable Cardioverter Defibrillator Therapy. [PDF]

Cureus
Akhtar R, Llewellyn J, Grant M.
europepmc   +1 more source

Chelation Therapy for Rare Earth Element Toxicity: Current Evidence, Challenges and Future Directions

Basic &Clinical Pharmacology &Toxicology, Volume 138, Issue 1, January 2026.
ABSTRACT The accelerating integration of rare earth elements (REEs) in advanced technologies has generated rising concern over human exposure and the attendant toxicological risks. This review presents an up‐to‐date synthesis of current evidence on REE toxicity across multiple exposure pathways, including inhalation, ingestion and occupational contact,
Jose L. Domingo
wiley   +1 more source

Arrhythmia-Induced Cardiomyopathy in Atrial Fibrillation: Pathogenesis, Diagnosis, and Treatment. [PDF]

Life (Basel)
Karakasis P, Theofilis P, Vlachakis PK, Apostolos A, Ktenopoulos N, Grigoriou K, Patoulias D, Antoniadis AP, Fragakis N.   +8 more
europepmc   +1 more source

Pharmacotherapy Risks in Rare Genetic Diseases: Cross‐Referencing ACMG Secondary Findings v3.2 List With Clinical Databases

Clinical and Translational Science, Volume 19, Issue 1, January 2026.
ABSTRACT Clinical genomics and pharmacogenomics have largely remained separate fields, though some genetic variants have overlapping disease risk and drug implications. However, the extent of this overlap is not well studied. To explore this gap, we cross‐referenced genes from the American College of Medical Genetics Secondary Findings v3.2 list with ...
Josiah D. Allen, Benjamin Q. Duong, Jordan Brady, Pamela Arn   +3 more
wiley   +1 more source

Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Atrial Fibrillation: Clinical Implications, Mechanisms, and Therapeutic Potential. [PDF]

Cureus
Ramadan MM, Jawish MK, Tamim O, Abdelbary MT, Al-Refai NH, Hady SM, Salama SA, Alhaboobi ZH, Abd-Alsamad YA, Alsabea HH, Allababidi MT, Alrais A, Zorek BH, Zorek SH, Saleh MA.   +14 more
europepmc   +1 more source

Relative efficacy of GLP‐1 and GLP‐1/GIP receptor agonists in the prevention of alcohol‐use disorders using a target trial emulation approach

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 137-150, January 2026.
Abstract Aims There is growing evidence that the GLP‐1 system is implicated in alcohol and other substance use disorders, and that GLP‐1‐based therapies may have therapeutic relevance in alcohol use disorder (AUD). We aimed to determine the impact of GLP‐1 based therapies on incident AUDs in a real‐world setting in patients with T2D.
Alex E. Henney, David R. Riley, Megan Heague, Carl A. Roberts, Theresa J. Hydes, Matthew Anson, David M. Hughes, Uazman Alam, Daniel J. Cuthbertson   +8 more
wiley   +1 more source

Arrhythmias, conduction disorders and sudden cardiac death in cancer patients and survivors: expert opinion of the working groups on cardio-oncology and on electrophysiology of the hellenic cardiac society. [PDF]

Cardiooncology
Keramida K, Kariki O, Angelopoulou E, Kalafatis I, Lafaras C, Letsas KP, Michalopoulou H, Saplaouras A, Tampakis K, Tsekoura D, Andrikopoulos G.   +10 more
europepmc   +1 more source

Targeting Calcium Regulation for Heart Failure and Arrhythmia Therapeutics: A Critical Review. [PDF]

Circulation
Redel-Traub G, Marx SO, Marks AR.
europepmc   +1 more source

Recent-onset atrial fibrillation: challenges and opportunities. [PDF]

Eur Heart J
Svennberg E, Freedman B, Andrade JG, Anselmino M, Biton Y, Boriani G, Brandes A, Buckley CM, Cameron A, Clua-Espuny JL, Crijns HJGM, Diederichsen SZ, Doehner W, Dominguez H, Duncker D, Fauchier L, Glotzer T, Guo YS, Haeusler KG, Haim M, Healey JS, Hendriks JM, Hills MT, Hindricks G, Hobbs FDR, Johnson LS, Joung B, Kamel H, Kirchhof P, Lane DA, Levin LÅ, Lip GYH, Liu S, Lobban T, Macfarlane PW, Mairesse GH, Marcus GM, Noseworthy PA, Ntaios G, Orchard JJ, Passman R, Reidpath DD, Reiffel JA, Ribeiro AL, Rivard L, Sanders P, Sandhu RK, Schnabel RB, Siontis KC, Sposato LA, Stavrakis S, Steinhubl SR, Svendsen JH, Teh AW, Themistoclakis S, Tieleman RG, Camm AJ.   +56 more
europepmc   +1 more source